GemVax&KAEL Co.Ltd
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution p… Read more
GemVax&KAEL Co.Ltd (082270) - Total Assets
Latest total assets as of September 2025: ₩157.67 Billion KRW
Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) holds total assets worth ₩157.67 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
GemVax&KAEL Co.Ltd - Total Assets Trend (2010–2024)
This chart illustrates how GemVax&KAEL Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
GemVax&KAEL Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
GemVax&KAEL Co.Ltd's total assets of ₩157.67 Billion consist of 16.7% current assets and 83.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩2.98 Billion | 0.4% |
| Accounts Receivable | ₩8.21 Billion | 5.5% |
| Inventory | ₩5.69 Billion | 3.8% |
| Property, Plant & Equipment | ₩36.55 Billion | 24.3% |
| Intangible Assets | ₩3.23 Billion | 2.1% |
| Goodwill | ₩46.82 Million | 0.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how GemVax&KAEL Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: GemVax&KAEL Co.Ltd's current assets represent 16.7% of total assets in 2024, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 0.4% of total assets in 2024, down from 6.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is property, plant & equipment at 24.3% of total assets.
GemVax&KAEL Co.Ltd Competitors by Total Assets
Key competitors of GemVax&KAEL Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Eugene Technology Co.Ltd
KQ:084370
|
Korea | ₩523.78 Billion |
|
Fidelix Co. Ltd
KQ:032580
|
Korea | ₩54.45 Billion |
|
Cloud Air Co.Ltd
KQ:036170
|
Korea | ₩157.42 Billion |
|
UNISEM Co. Ltd
KQ:036200
|
Korea | ₩275.09 Billion |
|
JUSUNG ENGINEERING Co. Ltd
KQ:036930
|
Korea | ₩871.61 Billion |
|
Lumens Co. Ltd
KQ:038060
|
Korea | ₩152.88 Billion |
|
meerecompany Incorporated
KQ:049950
|
Korea | ₩127.08 Billion |
|
I&C Technology Co. Ltd
KQ:052860
|
Korea | ₩53.55 Billion |
GemVax&KAEL Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - GemVax&KAEL Co.Ltd generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - GemVax&KAEL Co.Ltd is currently not profitable relative to its asset base.
GemVax&KAEL Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.51 | 1.16 | 3.31 |
| Quick Ratio | 0.39 | 0.87 | 3.05 |
| Cash Ratio | 0.00 | 0.48 | 0.00 |
| Working Capital | ₩-35.02 Billion | ₩ 5.20 Billion | ₩ 47.83 Billion |
GemVax&KAEL Co.Ltd - Advanced Valuation Insights
This section examines the relationship between GemVax&KAEL Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 35.30 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 11.5% |
| Total Assets | ₩150.75 Billion |
| Market Capitalization | $822.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values GemVax&KAEL Co.Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: GemVax&KAEL Co.Ltd's assets grew by 11.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for GemVax&KAEL Co.Ltd (2010–2024)
The table below shows the annual total assets of GemVax&KAEL Co.Ltd from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩150.75 Billion | +11.54% |
| 2023-12-31 | ₩135.15 Billion | -10.58% |
| 2022-12-31 | ₩151.14 Billion | -12.30% |
| 2021-12-31 | ₩172.34 Billion | +8.53% |
| 2020-12-31 | ₩158.80 Billion | -2.68% |
| 2019-12-31 | ₩163.18 Billion | -5.45% |
| 2018-12-31 | ₩172.59 Billion | +7.43% |
| 2017-12-31 | ₩160.66 Billion | -15.30% |
| 2016-12-31 | ₩189.68 Billion | +5.24% |
| 2015-12-31 | ₩180.23 Billion | +69.57% |
| 2014-12-31 | ₩106.29 Billion | -26.70% |
| 2013-12-31 | ₩145.00 Billion | +9.03% |
| 2012-12-31 | ₩132.99 Billion | +1.11% |
| 2011-12-31 | ₩131.52 Billion | +102.30% |
| 2010-12-31 | ₩65.01 Billion | -- |